Leyland-Jones, B.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Piccart-Gebhart, Martine J., Procter, Marion, Leyland-Jones, Brian, Goldhirsch, Aron, Untch, Michael, Smith, Ian, Gianni, Luca, Baselga, Jose, Bell, Richard, Jackisch, Christian, Cameron, David, Dowse

Journal:

Boston Medical and Surgical Journal

Year:

2005

Language:

english

File:

PDF, 149 KB

english, 2005

2

Utility of genomic analysis in circulating tumor DNA from patients with carcinoma of unknown primary

Kato, Shumei, Krishnamurthy, Nithya, Banks, Kimberly C., De, Pradip, Williams, Kirstin, Williams, Casey, Leyland-Jones, Brian, Lippman, Scott M., Lanman, Richard B., Kurzrock, Razelle

Journal:

Cancer Research

Year:

2017

Language:

english

File:

PDF, 1.37 MB

english, 2017

3

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus

Schrock, Alexa B., Pavlick, Dean C, Klempner, Samuel J., Chung, Jon H., Forcier, Brady, Welsh, Allison, Young, Lauren, Leyland-Jones, Brian, Bordonii, Rodolfo, Carvajal, Richard D, Chao, Joseph, Kurzr

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 4.71 MB

english, 2018

4

DNA derived from archival tumor specimens can be used for germline pharmacogenetic analyses

Hertz, Daniel L, Kidwell, Kelley M, Douglas, Julie A, Viale, Giuseppe, Leyland-Jones, Brian, Regan, Meredith, Rae, James M

Journal:

Pharmacogenomics

Year:

2020

File:

PDF, 336 KB

2020

5

Anthracycline analogs The past, present, and future

Raymond B. Weiss, Gisele Sarosy, Kathleen Clagett-Carr, Marianne Russo, Brian Leyland-Jones

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1986

Language:

english

File:

PDF, 1.37 MB

english, 1986

6

PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials

Dey, Nandini, De, Pradip, Leyland-Jones, Brian

Journal:

Pharmacology & Therapeutics

Year:

2017

Language:

english

File:

PDF, 775 KB

english, 2017

7

Proteomics: New technologies and clinical applications

Martin Latterich, Mark Abramovitz, Brian Leyland-Jones

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 117 KB

english, 2008

8

Comparative analysis of xanafide cytotoxicity in breast cancer cell lines

Alami, N, Paterson, J, Belanger, S, Juste, S, Grieshaber, C K, Leyland-Jones, B

Journal:

British Journal of Cancer

Year:

2007

Language:

english

File:

PDF, 157 KB

english, 2007

9

EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality

Milano, G, Spano, J-P, Leyland-Jones, B

Journal:

British Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 107 KB

english, 2008

10

2105 POSTER An accelerated loading regimen for trastuzumab leads to early higher than steady-state serum concentrations

B. Leyland-Jones, R. Colomer, M. Trudeau, A. Wardley, J. Latreille, D. Cameron, R. Cubedo, N. Al-Sakaff, J.E. Charoin, J. Cortés

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 60 KB

english, 2007

11

Utility of Serum HER2 Extracellular Domain Assessment in Clinical Decision Making: Pooled Analysis of Four Trials of Trastuzumab in Metastatic Breast Cancer

Lennon, S., Barton, C., Banken, L., Gianni, L., Marty, M., Baselga, J., Leyland-Jones, B.

Journal:

Journal of Clinical Oncology

Year:

2009

Language:

english

File:

PDF, 171 KB

english, 2009

12

ChemInform Abstract: Synthesis and Structure—Activity Relationships of 2-Pyrazinylcarboxamidobenzoates and β-Ionylideneacetamidobenzoates with Retinoidal Activity.

B. R. LEYLAND-JONES, ET AL. ET AL.

Journal:

Year:

1998

Language:

english

File:

PDF, 45 KB

english, 1998

13

Merbarone: an antitumor agent entering clinical trials

Alice Glover, Hoo G. Chun, Larry M. Kleinman, David A. Cooney, Jacqueline Plowman, Charles K. Grieshaber, Louis Malspeis, Brian Leyland-Jones

Journal:

Investigational New Drugs

Year:

1987

Language:

english

File:

PDF, 454 KB

english, 1987

14

Promises and caveats of in silico biomarker discovery

Leyland-Jones, B, Pusztai, L

Journal:

British Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 51 KB

english, 2008

15

Ifosfamide stereoselective dichloroethylation and neurotoxicity

I.W. Wainer, J. Ducharme, C.P. Granvil, M. Trudeau, B. Leyland-Jones

Journal:

Year:

1994

Language:

english

File:

PDF, 303 KB

english, 1994

16

A systems approach to clinical oncology: Focus on breast cancer

Mark Abramovitz, Brian Leyland-Jones

Journal:

Proteome Science

Year:

2006

Language:

english

File:

PDF, 808 KB

english, 2006

17

Hand-held Spectroscopic Device for In Vivo and Intraoperative Tumor Detection: Contrast Enhancement, Detection Sensitivity, and Tissue Penetration

Mohs, Aaron M., Mancini, Michael C., Singhal, Sunil, Provenzale, James M., Leyland-Jones, Brian, Wang, May D., Nie, Shuming

Journal:

Analytical Chemistry

Year:

2010

Language:

english

File:

PDF, 2.95 MB

english, 2010

18

CYP2D6 Genotype Should Not Be Used for Deciding About Tamoxifen Therapy in Postmenopausal Breast Cancer

Rae, J. M., Regan, M., Leyland-Jones, B., Hayes, D. F., Dowsett, M.

Journal:

Journal of Clinical Oncology

Year:

2013

Language:

english

File:

PDF, 73 KB

english, 2013

19

BOOK REVIEWS

LEYLAND-JONES, B.

Journal:

JNCI Journal of the National Cancer Institute

Year:

1989

Language:

english

File:

PDF, 226 KB

english, 1989

20

Design and mechanism of action of a novel cytotoxic 1,2,3-triazene-containing heterocycle, 3,5-dimethyl-pyrido-1,2,3,5-tetrazepin-4-one (PYRZ), in the human epithelial ovarian cancer cell line NIH:OVCAR-3 in vitro

Jean-Claude, BJ, Mustafa, A, Cetateanu, ND, Damian, Z, De Marte, J, Yen, R, Vasilescu, D, Chan, TH, Leyland-Jones, B

Journal:

British Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 1.07 MB

english, 1997

21

67P * DELETIONS AT 1P13.3 IS ASSOCIATED WITH SIGNIFICANTLY ADVERSE PROGNOSIS IN BREAST CANCER

Willis, S., Young, B., Leyland-Jones, B.

Journal:

Annals of Oncology

Year:

2013

Language:

english

File:

PDF, 28 KB

english, 2013

22

Homoharringtonine--perspectives on an active new natural product.

O'Dwyer, P J, King, S A, Hoth, D F, Suffness, M, Leyland-Jones, B

Journal:

Journal of Clinical Oncology

Year:

1986

File:

PDF, 527 KB

1986

23

Arabinosyl-5-azacytosine: A novel nucleoside entering clinical trials

Jean L. Grem, D. Dale Shoemaker, Daniel F. Hoth, Susan A. King, Jacqueline Plowman, Daniel Zaharko, Charles K. Grieshaber, Steadman D. Harrison, James C. Cradock, Brian Leyland-Jones

Journal:

Investigational New Drugs

Year:

1987

Language:

english

File:

PDF, 1022 KB

english, 1987

24

Of mice and men: the evolution of animal welfare guidelines for cancer research

Dey, N, De, P, Smith, B R, Leyland-Jones, B

Journal:

British Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 110 KB

english, 2010

25

Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping

P Wong, K Banerjee, J Massengill, S Nowell, N Lang, B Leyland-Jones

Journal:

Journal of Immunological Methods

Year:

2001

Language:

english

File:

PDF, 247 KB

english, 2001

26

Evidence for erythropoietin as a molecular targeting agent

Brian Leyland-Jones

Journal:

Seminars in Oncology

Year:

2002

Language:

english

File:

PDF, 112 KB

english, 2002

27

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Slamon, Dennis J., Leyland-Jones, Brian, Shak, Steven, Fuchs, Hank, Paton, Virginia, Bajamonde, Alex, Fleming, Thomas, Eiermann, Wolfgang, Wolter, Janet, Pegram, Mark, Baselga, Jose, Norton, Larry

Journal:

Boston Medical and Surgical Journal

Year:

2001

Language:

english

File:

PDF, 199 KB

english, 2001

28

[Cancer Drug Discovery and Development] PI3K-mTOR in Cancer and Cancer Therapy || Phospho-Inositol-3-Kinase Activity and Dysregulation in Pediatric Leukemia and Lymphoma

Dey, Nandini, De, Pradip, Leyland-Jones, Brian

Year:

2016

Language:

english

File:

PDF, 789 KB

english, 2016

29

N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer.

Clagett-Carr, K, Sarosy, G, Plowman, J, Hoth, D F, Leyland-Jones, B

Journal:

Journal of Clinical Oncology

Year:

1988

File:

PDF, 1.05 MB

1988

30

274 Insulin-like growth factor-binding protein 3: single-agent and synergistic effects with paclitaxel in breast tumour models

Q. Yu, L. Jerome, V. Page, K. Banerjee, L. Shiry, B. Leyland-Jones

Journal:

European Journal of Cancer Supplements

Year:

2004

Language:

english

File:

PDF, 149 KB

english, 2004

31

Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial

Metzger-Filho, O., Procter, M., de Azambuja, E., Leyland-Jones, B., Gelber, R. D., Dowsett, M., Loi, S., Saini, K. S., Cameron, D., Untch, M., Smith, I., Gianni, L., Baselga, J., Jackisch, C., Bell, R

Journal:

Journal of Clinical Oncology

Year:

2013

Language:

english

File:

PDF, 227 KB

english, 2013

32

Role of Herceptin® in Primary Breast Cancer: Views from North America and Europe

Leyland-Jones, Brian, Smith, Ian

Journal:

Year:

2001

Language:

english

File:

PDF, 147 KB

english, 2001

33

Whither HER2-Related Therapeutics?

De, P., Leyland-Jones, B.

Journal:

Journal of Clinical Oncology

Year:

2010

Language:

english

File:

PDF, 368 KB

english, 2010

34

Dose Scheduling – Herceptin®

Leyland-Jones, Brian

Journal:

Year:

2001

Language:

english

File:

PDF, 145 KB

english, 2001

35

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence

Ignatiadis, Michail, Azim, Hatem A., Desmedt, Christine, Veys, Isabelle, Larsimont, Denis, Salgado, Roberto, Lyng, Maria B., Viale, Giuseppe, Leyland-Jones, Brian, Giobbie-Hurder, Anita, Kammler, Rosi

Journal:

Year:

2015

Language:

english

File:

PDF, 428 KB

english, 2015

36

A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Leyland-Jones, B., Bondarenko, I., Nemsadze, G., Smirnov, V., Litvin, I., Kokhreidze, I., Abshilava, L., Janjalia, M., Li, R., Lakshmaiah, K. C., Samkharadze, B., Tarasova, O., Mohapatra, R. K., Spary

Journal:

Journal of Clinical Oncology

Year:

2016

Language:

english

File:

PDF, 1.01 MB

english, 2016

37

Tamoxifen metabolic patterns within a glioma patient population treated with high-dose tamoxifen

Julie Ducharme, Karen Fried, George Shenouda, Brian Leyland-Jones, Irving W. Wainer

Journal:

British Journal of Clinical Pharmacology

Year:

1997

Language:

english

File:

PDF, 254 KB

english, 1997

38

CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

Regan, M. M., Leyland-Jones, B., Bouzyk, M., Pagani, O., Tang, W., Kammler, R., Dell'Orto, P., Biasi, M. O., Thurlimann, B., Lyng, M. B., Ditzel, H. J., Neven, P., Debled, M., Maibach, R., Price, K. N

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 529 KB

english, 2012

39

586 POSTER Inhibition of mTOR and targeting insulin-like growth factor I synergistically enhance taxol-induced cytotoxicity in Her-2 overexpressing breast cancer cells

N. Alami, Z. Li, L. Shiry, B. Leyland-Jones

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 60 KB

english, 2006

40

The Future of Breast Cancer Therapy: Erythropoietin as an Integral Component

Brian Leyland-Jones

Journal:

Clinical Breast Cancer

Year:

2003

Language:

english

File:

PDF, 88 KB

english, 2003

41

Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab-refractory breast cancer model

Sun, Yuliang, Dey, Nandini, Brammer, Melissa, De, Pradip, Leyland-Jones, Brian

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 1.44 MB

english, 2013

42

Mutation matters in precision medicine: A future to believe in

Dey, Nandini, Williams, Casey, Leyland-Jones, Brian, De, Pradip

Journal:

Cancer Treatment Reviews

Year:

2017

Language:

english

File:

PDF, 1.58 MB

english, 2017

43

A molecular cytogenetic approach to studying platinum resistance

L.R Hiorns, M.J Seckl, F Paradinas, S.Y Sharp, L.A Skelton, G Brunstrom, E.S Newlands, L.R Kelland, B Leyland-Jones

Journal:

Journal of Inorganic Biochemistry

Year:

1999

Language:

english

File:

PDF, 1.12 MB

english, 1999

44

A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP

Brenda J. Foster, Bonnie J. Harding, Mary K. Wolpert-DeFilippes, Lawrence Y. Rubinstein, Kathleen Clagett-Carr, Brian Leyland-Jones

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1990

Language:

english

File:

PDF, 913 KB

english, 1990

45

Pharmacokinetics of herceptin administered three-weekly compared to weekly — A simulation based on data from the clinical studies

P. Ghahramani, C. Barton, B. Leyland-Jones

Journal:

Year:

2003

Language:

english

File:

PDF, 221 KB

english, 2003

46

Optimizing treatment of HER2-positive metastatic breast cancer

Alison L. Jones, Brian Leyland-Jones

Journal:

Seminars in Oncology

Year:

2004

Language:

english

File:

PDF, 141 KB

english, 2004

47

Genomic Imbalances Associated with Acquired Resistance to Platinum Analogues

Brian Leyland-Jones, Lloyd R. Kelland, Kenneth R. Harrap, Lynne R. Hiorns

Journal:

The American Journal of Pathology

Year:

1999

Language:

english

File:

PDF, 620 KB

english, 1999

48

Phase I Study of Elliptinium (2-N-Methyl-9-Hydroxyellipticinium)

Einzig, Avi I., Gralla, Richard J., Leyland-Jones, Brian R., Kelsen, David P., Cibas, Irene, Lewis, Ellen, Greenberg, And Ernest

Journal:

Cancer Investigation

Year:

1985

Language:

english

File:

PDF, 417 KB

english, 1985

49

Stereoselective pharmacokinetics of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in female cancer patients

Camille P. Granvil, Julie Ducharme, Brian Leyland-Jones, Marc Trudeau, Irving W. Wainer

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1996

Language:

english

File:

PDF, 1.56 MB

english, 1996

50

Concordance Between CYP2D6 Genotypes Obtained From Tumor-Derived and Germline DNA

Rae, J. M., Regan, M. M., Thibert, J. N., Gersch, C., Thomas, D., Leyland-Jones, B., Viale, G., Pusztai, L., Hayes, D. F., Skaar, T., Van Poznak, C.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2013

Language:

english

File:

PDF, 294 KB

english, 2013

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски